Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACELARATE: Acelarin vs Gemcitabine in Metastatic Pancreatic Carcinoma
NCT03610100Phase 3Suspended
- Start
- Dec 2015
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pracinostat in pancreatic carcinoma. Started Dec 2015; status: suspended.
02
Drugs
pracinostat
03
Conditions
pancreatic carcinoma
Beyond the preview
Go deeper on NCT03610100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03610100.